Claudio Larosa
Catholic University of the Sacred Heart
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by Claudio Larosa.
Journal of Cardiovascular Medicine | 2008
Claudio Larosa; Gregory A. Sgueglia; Alfonso Sestito; Fabio Infusino; Giampaolo Niccoli; Priscilla Lamendola; Luca Mariani; Pasquale Santangeli; Antonella Lombardo; Filippo Crea; Gaetano Antonio Lanza
Objective To investigate the determinants and prognostic value of heart rate variability (HRV) in acute myocardial infarction (AMI) patients treated by percutaneous coronary intervention (PCI). Methods We studied 64 patients with AMI (58.4 ± 10 years, 56 men), treated by PCI within 12 h of symptom onset. Patients underwent 24-h electrocardiographic Holter recording before discharge. HRV was measured in the time- and frequency-domain. Cardiac events were assessed at 6 months. Results At univariate analysis, Thrombolysis in Myocardial Infarction (TIMI) flow grade < 3 was significantly predictive of reduced frequency-domain variables. On multivariate analysis, diabetes and pre-PCI time > 6 h were the strongest predictors of depressed HRV, with peak creatine kinase myocardial-type and lower left ventricular ejection fraction being also variably correlated with impaired HRV. At 6-month follow-up, seven patients (10.1%) had cardiac events (one AMI, six revascularization procedures). A low standard deviation of RR intervals was a significant predictor of events (P = 0.009), although only age was associated with the endpoint (P = 0.05) on multivariate analysis. Conclusions Our study shows that, in AMI patients treated by primary PCI, a delay in coronary revascularization and AMI extension are key factors for determining depressed HRV.
International Journal of Cardiology | 2016
Alessandro Durante; Giovanni Foglia Manzillo; Francesco Burzotta; Carlo Trani; Cristina Aurigemma; Francesco Summaria; Roberto Patrizi; Giovanni Paolo Talarico; Azeem Latib; Filippo Figini; Enrico Romagnoli; Mariarosaria De Vita; Cecilia Fantoni; Luigi My; Claudio Larosa; Alessandro Manzoli; Maurizio Turturo; Andrea Berni; Giovanni Corrado
BACKGROUND Diffuse coronary artery disease treatment still remains a challenge for interventional cardiologists and cardiac surgeons. There are few data on full metal jacket (FMJ) stenting, especially with new-generation drug-eluting stents. We aimed to assess the efficacy and safety of FMJ with new-generation Zotarolimus-eluting stents (n-ZES). METHODS AND RESULTS All patients who underwent FMJ with n-ZES (≥60mm stent length) in eleven Italian interventional centers participating in the Clinical Service® project were included in this analysis. The project population consisted of 120 patients and 122 lesions. Mean age was 67±10years and 95 (79.2%) patients were male. A chronic total occlusion was present in 34 lesions (27.9%). The number of stents implanted per lesion was 2.9±0.8, and the diameter of the stents was 3.0±0.5mm. Predilation and post-dilatation were performed in 107 (87.7%) and 92 (75.4%) patients, respectively. At 41±21month follow-up there were 2 patients with subacute definite stent thrombosis, 6 patients (5.0%) had cardiac death and 5 patients (4.2%) had non-fatal myocardial infarction. Seven patients (5.8%) underwent clinically-driven target lesion revascularization. Fourteen patients (11.7%) had at least one major adverse cardiac event. CONCLUSION The treatment of diffuse coronary artery disease with FMJ stenting with n-ZES appears to be effective and safe. Late and very-late ST does not seem to be an issue and the rate of restenosis and of major cardiac adverse events after more than 3-year follow-up is rather low.
Catheterization and Cardiovascular Interventions | 2016
Francesco Burzotta; Francesco Summaria; Azeem Latib; Maria De Vita; Cecilia Fantoni; Stefano Benedetto; Maurizio Turturo; Claudio Larosa; Alessandro Manzoli; Carlo Trani
To assess the “real world” clinical outcome of patients with bifurcated lesions undergoing percutaneous coronary intervention with implantation of second and third generations of zotarolimus‐eluting stent.
Cardiovascular Revascularization Medicine | 2014
Italo Porto; Claudio Larosa; Isabella Rosa; Francesco Burzotta; Carlo Trani
We describe our solution to the unusual situation of an inflated, large coronary stent (3.5 mm diameter) which became dislodged from the ostium of the right coronary artery after deployment during a transradial procedure. We discussed tips for retrieval from the radial artery while preserving the access for completion of the procedure.
Journal of Cardiovascular Medicine | 2008
Italo Porto; Claudio Larosa; Giampaolo Niccoli; Antonio Maria Leone; Francesco Burzotta; Luca Testa; William J. van Gaal; Gaetano Antonio Lanza; Filippo Crea
Guidewires used during percutaneous coronary interventions have elevated conductance, and, when in place, are electrically isolated from the body fluids by the guiding catheter. In this paper, we present an overview of two simple techniques exploiting these unique conditions to record local electrical activity in the myocardium and to pace the heart. Both actions can be accomplished with standard catheterization laboratory equipment. The operator may obtain useful, real-time information on distal ischemia and/or vitality and react quickly when an emergency pacing is required. The technical details of these techniques are elucidated and their usefulness as clinical and research tools is discussed, with an emphasis on possible future applications.
Annals of Noninvasive Electrocardiology | 2007
Fabio Infusino; Gaetano Antonio Lanza; Claudio Larosa; Gregory A. Sgueglia; Leonardo Marinaccio; Priscilla Lamendola; Luca Mariani; Pasquale Santangeli; Alfonso Sestito; Filippo Crea
Objectives: To get insight in the mechanism of exercise‐induced ST‐segment elevation (STE) in patients with Q/QS waves at the electrocardiogram (ECG).
Thrombosis Research | 2005
Alfonso Sestito; Antonella Maccallini; Gregory A. Sgueglia; Fabio Infusino; Claudio Larosa; Cristina Aurigemma; Filippo Crea; Gaetano Antonio Lanza
Eurointervention | 2011
Italo Porto; Flavia Belloni; Giampaolo Niccoli; Claudio Larosa; Antonio Maria Leone; Francesco Burzotta; Carlo Trani; Giovanni Luigi De Maria; C. Hamilton-Craig; Filippo Crea
Minerva Cardioangiologica | 2007
Pasquale Santangeli; Priscilla Lamendola; Claudio Larosa; Antonella Lombardo; Alfonso Sestito; Fabio Infusino; Gregory A. Sgueglia; Luca Mariani; Leonardo Marinaccio; Lanza Ga; F. Crea
Italian heart journal: official journal of the Italian Federation of Cardiology | 2005
Claudio Larosa; Fabio Infusino; Gregory A. Sgueglia; Cristina Aurigemma; Alfonso Sestito; Antonella Lombardo; Giampaolo Niccoli; Filippo Crea; Gaetano Antonio Lanza